Table 3b.
Clinical outcome among patients with different genotypes.
| Variables | GG (n = 58) No. (%) |
GC (n = 55) No. (%) |
CC (n = 37) | P value |
|---|---|---|---|---|
| Hospitalized | 43 (74.1)⁎ | 22 (40.0) | 13 (35.1) | <0.001 |
| Respiratory failure (So2 < 90) | 34 (61.8)⁎ | 1 (1.9) | 4 (11.8) | <0.001 |
| Complications | ||||
| Thromboembolic | 15 (26.3) | 1 (1.8) | 1 (2.7) | <0.001 |
| Renal complications | 7 (12.1) | 7 (12.7) | 1 (2.7) | 0.225 |
| Cardiac complications | 13 (22.4)† | 1 (1.8) | 1 (2.7) | <0.001 |
| ICU admission | 16 (27.6) | 1 (1.8)† | 6 (16.2) | 0.001 |
| Mechanical ventilation | 12 (21.1)⁎ | 1 (1.8) | 1 (2.7) | 0.001 |
| Severity categorization | ||||
| Mild | 12 (21.1) | 27 (49.1)⁎ | 12 (32.4) | <0.001 |
| Moderate | 12 (21.1) | 15 (27.3) | 15 (40.5)⁎ | |
| Severe | 18 (31.6) | 12 (21.8) | 4 (10.8)† | |
| Critically ill | 15 (26.3) | 1 (1.8)† | 6 (16.2) | |
| Mortality | 4 (6.9) | 1 (1.8) | 1 (2.7) | 0.505 |
⁎
Significantly higher than their corresponding in the other groups.
†
Significantly lower than their corresponding in the other groups.